#JPM19 starts with Eli Lilly's $8B buyout of Loxo Oncology — so who's next?
Eli Lilly $LLY has paid $8 billion to jump the queue and take a leading role in an emerging — though still small — field of oncology.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
